SPC Financial Inc. trimmed its position in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 4.9% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,805 shares of the financial services provider’s stock after selling 144 shares during the quarter. SPC Financial Inc.’s holdings in CME Group were worth $619,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently made changes to their positions in the company. Salomon & Ludwin LLC bought a new position in shares of CME Group in the 1st quarter worth about $28,000. Y.D. More Investments Ltd bought a new position in shares of CME Group during the second quarter valued at approximately $36,000. Thurston Springer Miller Herd & Titak Inc. lifted its holdings in shares of CME Group by 62.2% during the third quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock valued at $43,000 after purchasing an additional 74 shares during the last quarter. McClarren Financial Advisors Inc. boosted its position in shares of CME Group by 66.1% in the 2nd quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock worth $39,000 after purchasing an additional 78 shares in the last quarter. Finally, Asset Dedication LLC boosted its position in shares of CME Group by 515.2% in the 2nd quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock worth $40,000 after purchasing an additional 170 shares in the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.
Analyst Ratings Changes
A number of research analysts have issued reports on the company. Bank of America lifted their price objective on CME Group from $177.00 to $180.00 and gave the company an “underperform” rating in a research note on Thursday, October 3rd. The Goldman Sachs Group lifted their price target on CME Group from $195.00 to $198.00 and gave the stock a “sell” rating in a research report on Thursday, October 3rd. Deutsche Bank Aktiengesellschaft raised their price objective on shares of CME Group from $193.00 to $200.00 and gave the company a “hold” rating in a research note on Thursday, August 15th. Morgan Stanley lifted their target price on shares of CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a report on Thursday. Finally, JPMorgan Chase & Co. increased their price target on shares of CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a report on Thursday, July 25th. Four research analysts have rated the stock with a sell rating, seven have given a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $220.07.
Insiders Place Their Bets
In related news, CFO Lynne Fitzpatrick sold 754 shares of CME Group stock in a transaction on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total transaction of $163,610.46. Following the transaction, the chief financial officer now directly owns 13,261 shares in the company, valued at approximately $2,877,504.39. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, CFO Lynne Fitzpatrick sold 754 shares of the firm’s stock in a transaction dated Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the transaction, the chief financial officer now owns 13,261 shares of the company’s stock, valued at $2,877,504.39. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Bryan T. Durkin sold 7,593 shares of the business’s stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the transaction, the director now owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.30% of the company’s stock.
CME Group Price Performance
NASDAQ CME opened at $227.23 on Friday. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a 1-year low of $190.70 and a 1-year high of $230.12. The stock has a market capitalization of $81.82 billion, a price-to-earnings ratio of 25.85, a PEG ratio of 7.76 and a beta of 0.55. The business’s fifty day moving average price is $216.48 and its 200-day moving average price is $208.28.
CME Group (NASDAQ:CME – Get Free Report) last posted its earnings results on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share for the quarter, beating analysts’ consensus estimates of $2.53 by $0.03. The company had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.53 billion. CME Group had a return on equity of 12.82% and a net margin of 56.98%. CME Group’s revenue was up 12.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.30 earnings per share. On average, equities analysts predict that CME Group Inc. will post 10.04 earnings per share for the current year.
CME Group Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th were issued a dividend of $1.15 per share. The ex-dividend date was Monday, September 9th. This represents a $4.60 dividend on an annualized basis and a yield of 2.02%. CME Group’s dividend payout ratio is currently 52.33%.
CME Group Company Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Articles
- Five stocks we like better than CME Group
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Taiwan Semiconductor Soars on Earnings With More Room to Run
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Is Lucid Group Nearing the Bottom? What Investors Should Know
- Dividend Payout Ratio Calculator
- 90% Gain Possible? Analysts Are Bullish on Joby Aviation
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.